Patents Assigned to Bayer Pharma Aktiengesekkschaft
  • SUBSTITUTED N,2-DIARYLQUINOLINE-4-CARBOXAMIDES AND THE USE THEREOF AS ANTI-INFLAMMATORY AGENTS
    Publication number: 20170260140
    Abstract: The present application relates to novel substituted N,2-diarylquinoline-4-carboxamide derivatives, to processes for preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of fibrotic and/or inflammatory disorders.
    Type: Application
    Filed: September 7, 2015
    Publication date: September 14, 2017
    Applicant: Bayer Pharma Aktiengesekkschaft
    Inventors: Hartmut BECK, Tobias THALER, Raimund KAST, Daniel MEIBOM, Mark MEININGHAUS, Carsten TERJUNG, Martina DELBECK, Klemens LUSTIG, Uwe MUENSTER, Britta OLENIK